Edwards Lifesciences (EW)

Investing Cash Flow

-$912.10M

TTM · Period ending: · USD

EW logo

EW Investing Cash Flow

Latest reported-$912.10M
EW TTM Cash from Investing (-$75.00M → -$912.10M)
High-resolution chart · PNG

EW investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-912,100,000
-891,000,000
-712,900,000
-1,091,300,000
2,038,200,000
2,335,100,000
2,312,900,000
2,903,700,000
291,000,000
236,400,000
173,800,000
254,400,000
-36,100,000
23,300,000
252,300,000
-808,300,000
-984,200,000
-1,443,300,000
-1,722,500,000
-1,016,499,999
-765,399,999
-446,099,999
-531,099,999
-716,500,000
-602,900,000
-681,000,000
-595,800,000
-144,800,000
-386,300,000
-193,100,000
76,700,000
120,300,000
165,000,000
-578,100,000
-647,200,000
-616,300,000
-402,900,000
-107,800,000
-211,700,000
-264,600,000
-444,100,000
-88,500,000
-316,100,000
-231,400,000
-210,600,000
-693,500,000
-633,000,000
-991,900,000
-958,500,000
-560,000,000
-412,700,000
-150,100,000
-160,600,000
-131,400,000
-90,500,000
-437,600,000
-323,300,000
-291,900,000
-412,800,000
-104,500,000
-102,100,000
-107,500,000
-61,500,000
-54,300,000
14,200,000
16,300,000
40,100,000
39,200,000
-16,300,000
-6,800,000
58,800,000
-17,100,000
-29,300,000
-40,000,000
-144,500,000
-59,200,000
-60,500,000
-52,300,000
-35,700,000
-37,100,000
-33,000,000
-35,000,000
-27,200,000
-36,900,000
-44,100,000
-41,900,000
-177,100,000
-178,900,000
-172,500,000
-183,300,000
-63,300,000
-82,600,000
-80,700,000
-73,200,000
-68,300,000
-40,600,000
-41,700,000
1,900,000
-4,000,000
-2,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.